Agios Pharmaceuticals (AGIO) Other Non-Current Liabilities (2012 - 2026)
Agios Pharmaceuticals' Other Non-Current Liabilities came in at $240,000 for Q2 2026, up 137.6% from $101,000 a year earlier and up 166.7% from the prior quarter.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Agios Pharmaceuticals' Other Non-Current Liabilities was $90,000, down 89.8% from FY2024.
- Other Non-Current Liabilities has declined in each of the last three years, with a three-year compound annual growth rate of -69.8% (FY2022 to FY2025).
- Going back by year, Other Non-Current Liabilities was $880,000 in FY2024 (-23.9%), $1.16 million in FY2023 (-64.7%) and $3.28 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q1 2025.
- Year-over-year, Other Non-Current Liabilities increased in 1 of the last eight quarters, with an average decline of 34.1%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2026 (growth of 137.6%), and the weakest in Q3 2025 (a decline of 92.2%).
- Business Quant data shows AGIO's Other Non-Current Liabilities at $90,000 (Q1 2026), $90,000 (Q4 2025) and $90,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Agios Pharmaceuticals | 1.98 Bn | 1.98 Bn | 41.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240,000.00 |
| Mar 31, 2026 | 90,000.00 |
| Dec 31, 2025 | 90,000.00 |
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 101,000.00 |
| Mar 31, 2025 | 880,000.00 |
| Dec 31, 2024 | 880,000.00 |
| Sep 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 3.28 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Jun 30, 2020 | 491,000.00 |
| Mar 31, 2020 | 571,000.00 |
| Dec 31, 2019 | 673,000.00 |
API Access
Agios Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AGIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();